Companies of all sizes need to make timely decisions to ensure that in-house portfolio and in-licensing projects achieve long-term commercial success and profitability. tranScrip’s scientific, clinical and commercial experts have the appropriate therapeutic knowledge and strategic insights to advise and guide clients on internal pipeline and external opportunities as part of their portfolio management to ensure commercial success.
tranScrip’s Portfolio Management and Commercial Strategy team has worked on assessment of in-house and in-licensing opportunities for clients of all sizes. These assessments have covered all phases of development and extend across a wide variety of therapeutic areas. tranScrip is able to mobilise multifunctional teams with appropriate therapeutic, operational and / or strategic expertise to quickly and efficiently help clients with their future decision making.
The services that tranScrip provides include, but are not limited to:
- Data review and commercial gap analysis
- Review and analysis of Target Product Profiles
- Assessment of medical need and commercial viability
- Market and product patient based forecast modelling
- Creation/review of regulatory and development strategies
- Identification of key milestones in the development programme
This case study presents an example of tranScrip’s role in gaining an investment decision leading to the implementation of clinical development.
An investment house needed an assessment of a company portfolio of pre-clinical candidates and the potential for return of investment in the therapeutic area to enable a major funding decision.
tranScrip performed a comprehensive review of the therapeutic area including competitive intelligence and assessment of drug candidates.
A positive investment decision was made and the clinical development programme started, with tranScrip providing clinical development support.